予約・お問い合わせ
097-558-5600
     (受付時間 8:30 - 17:30)
ホーム
Home
内科について
Consultation
骨粗鬆症
Osteoporosis
スタッフ紹介
Doctors
アクセス
Access Map

文献

1)鈴木隆雄. 骨量の自然史と骨粗鬆症,骨折の予防戦略. 日臨床2004; 62(増2) : 225-32.

2)岡本純明:骨粗鬆症学-基礎・臨床研究の新しいパラダイム-.日本臨床62:637-654、2004

3)Albright F, Smith PH, Richardson AM. Postmenopausal osteoporosis―its clinical feature. JAMA 1941 ; 116 : 2465―2474

4) Leib ES, Lewiecki EM, Binkley N, et al. Official positions of the international society for clinical densitometry. J Clin Densitom2004; 7: 1-6.
Steiger P, Cummings SR, Black DM, et al. Age-related decrements in bone mineral density in women over 65. J Bone Miner Res 1992; 7: 625-32.

5) UNSCEAR2000年報告書, ICRP2007年勧告,日本放射線技師会医療被曝ガイドラインより

6) 岡本純明.桐山健:椎体骨折に続発する変形性脊椎症(OP-OA-OP症候群).CLINICAL CALCIUM 10(1)85-90.2000

7) J.W. Blunt, H.F. DeLuca & H.K. Scnoes: Biochemistry, 7, 3317 (1968).

8) Mackey DC, Black DM, Bauer DC, et al. Effects of antiresorptive treatment on nonvertebral fracture outcomes. J Bone Miner Res 2011;26:2411-8.
Black DM etal: Randomized Trial of Effect of Alendronate on Risk of Fracture in Women with ExistingVertebral Fractures. Lancet 348:1535-1541,1996.

9,10) Ogura Y et al;Clinical trial of risedronate in Japanese volunteers:a study on the effects of timing of dosing on absorption. J Bone Miner Metab 22 : 120-126, 2004

11)ボナロンバッグ基礎データより引用

12) Lindsay R et al; Randomized Controlled Study of Effect of Parathyroid Hormone on Vertebral-Bone Mass and Fracture Incidence among Postmenopausal Women on Oestrogen with Osteoporosis; Lancet 350(Aug 23), 550-555,1999

13) Ettinger B et al:Reduction of Vertebral Fracture Risk of Postmenopausal Women with Osteoporosis treated with Raloxifene: Results from 3-year Randomized Clinical Trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators JAMA 282:637-645,1999